Comparing two acne gels for moderate acne
Part of Skin clinical trials.
This study compares two prescription gels — metronidazole and clindamycin — to see which works better for moderate acne. You would apply one of the gels to your face and be monitored for improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between the ages of 18 and 35
- Have moderate acne (not mild or very severe)
- Not be using any other acne treatment right now
- Not be pregnant or breastfeeding
- Have no allergy to metronidazole or clindamycin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three different gels for treating mild to moderate acne on the face. One gel contains standard acne medication, another adds a steroid, and the third uses a special ingredient from stem cells (called secretome) to see which works best and is safest.
This trial compares two topical creams, clascoterone and adapalene, to see which works better for mild acne. If you have mild acne and are between 12 and 35, you might be able to join.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This study tests a new cream (clascoterone) for moderate to severe acne. The cream is applied to the face to reduce pimples and is compared to a placebo (a cream without the active ingredient).
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This study tests a new acne gel made from dutasteride (a medication often used for hair loss) against a standard three-ingredient prescription gel. It aims to see if the dutasteride gel is safe and works well for treating facial acne.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.